|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/113 | |
| A61K 31/7088 |
| (11) | Patento numeris | 3129485 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15721376.0 |
| Europos patento paraiškos padavimo data | 2015-04-01 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-02-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-06-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/023960 |
| Data | 2015-04-01 |
| (87) | Numeris | WO 2015/157070 |
| Data | 2015-10-15 |
| (30) | Numeris | Data | Šalis |
| 201461977488 P | 2014-04-09 | US |
| (72) |
REYON, Deepak, US
MAEDER, Morgan, L., US
FRIEDLAND, Ari, E., US
WELSTEAD, G., Grant, US
BUMCROT, David, A., US
|
| (73) |
Editas Medicine, Inc.,
300 Third Street First Floor, Cambridge, MA 02142,
US
|
| (54) | CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING CYSTIC FIBROSIS |
| CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING CYSTIC FIBROSIS |